SCLXW Scilex Holding Co
Price Chart
Executive Summary
Scilex's indirect subsidiary ACEA Therapeutics agreed to sell 100% of ACEA Pharma to Phoenix Asia Holdings in exchange for 100 million newly-issued Phoenix shares valued at $1 billion, after which ACEA Thera will own ~82% of the renamed combined company. This reverse merger effectively monetizes Scilex's stake in ACEA Pharma at a substantial valuation relative to Scilex's current market cap.
Key Financial Metrics
Actionable Insight
Monitor for Nasdaq and regulatory approvals, which are conditions to close. If completed, Scilex will effectively control a newly public biotech entity, potentially re-rating its own valuation. Watch for any material adverse changes or deal termination risks.
Key Facts
- Deal value agreed at $1,000,000,000 for 100,000,000 Phoenix shares at $10.00 each.
- Upon closing, ACEA Thera (Scilex subsidiary) will own approximately 82% of the combined entity.
- Phoenix Asia Holdings (PHOE) will be renamed ACEA Pharma, Inc. and continue trading on Nasdaq.
- Closing expected in Q2 2026 subject to regulatory, Nasdaq, and customary conditions.
Financial Impact
The $1 billion deal valuation represents a massive multiple of Scilex's <$2M warrant market cap, potentially unlocking significant value for Scilex shareholders.
Risk Factors
- Deal may fail to close due to regulatory or stock exchange issues.
- No financials of ACEA Pharma disclosed; valuation may not be realized.
- Scilex warrants (SCLXW) may see price volatility based on deal progress.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-205839 |
| Document: sclx-ex99_1.htm | 0001193125-26-205839 |
| Document: 0001193125-26-205839-index-headers.html | 0001193125-26-205839 |
| Document: 0001193125-26-205839-index.html | 0001193125-26-205839 |
| Document: 0001193125-26-205839.txt | 0001193125-26-205839 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
7d ago
|
S-3
| $0.1360 $0.1360 | · 0.00% | ▲ +0.40% | $0.1360 (−0.00%) |
|
May 26, 2026
15d ago
|
EFFECT
| $0.1360 $0.1360 | · 0.00% | ▲ +0.01% | $0.1360 (−0.00%) |
|
May 5, 2026
5w ago
|
8-K
| $0.1360 $0.1360 | · 0.00% | ▼ −1.38% | $0.1360 (+0.00%) |
|
Apr 28, 2026
6w ago
|
8-K
| $0.1360 $0.1360 | · 0.00% | ▼ −1.02% | $0.1360 (+0.00%) |
|
Apr 16, 2026
7w ago
|
S-3
| $0.1360 $0.1360 | · 0.00% | ▲ +0.19% | $0.1360 (+0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access